LEDYENSKA BALLESTEROS: Open Payments
NPI 1114167962 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,483 in 44 payments from 6 companies in 2025. Trend: 2023 $5,595 · 2024 $7,288 · 2025 $8,483
Consulting: $5,366Travel & lodging: $1,695Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $8,086 |
| Lilly USA, LLC | 13 | $208 |
| Corcept Therapeutics | 3 | $67 |
| ABBVIE INC. | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $36 |
Products named: Wegovy, MOUNJARO, Rybelsus, Korlym, ZEPBOUND, VRAYLAR, Kerendia, REXULTI.
Industry payments across TX — which companies pay providers there.
